ZA765331B - Novel pharmaceutically active compounds - Google Patents

Novel pharmaceutically active compounds

Info

Publication number
ZA765331B
ZA765331B ZA765331A ZA765331A ZA765331B ZA 765331 B ZA765331 B ZA 765331B ZA 765331 A ZA765331 A ZA 765331A ZA 765331 A ZA765331 A ZA 765331A ZA 765331 B ZA765331 B ZA 765331B
Authority
ZA
South Africa
Prior art keywords
active compounds
pharmaceutically active
novel pharmaceutically
novel
compounds
Prior art date
Application number
ZA765331A
Other languages
English (en)
Inventor
L Svensson
L Sorenby
K Wetterlin
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of ZA765331B publication Critical patent/ZA765331B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA765331A 1975-10-01 1976-09-07 Novel pharmaceutically active compounds ZA765331B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7510988A SE7510988L (sv) 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar

Publications (1)

Publication Number Publication Date
ZA765331B true ZA765331B (en) 1977-08-31

Family

ID=20325688

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA765331A ZA765331B (en) 1975-10-01 1976-09-07 Novel pharmaceutically active compounds

Country Status (19)

Country Link
JP (1) JPS5242840A (instruction)
AT (1) AT347427B (instruction)
AU (1) AU503212B2 (instruction)
BE (1) BE846837A (instruction)
CS (2) CS199643B2 (instruction)
DD (1) DD126278A5 (instruction)
DE (1) DE2640972A1 (instruction)
DK (1) DK141622B (instruction)
ES (1) ES451979A1 (instruction)
FI (1) FI762660A7 (instruction)
FR (1) FR2326183A1 (instruction)
GB (1) GB1542317A (instruction)
LU (1) LU75916A1 (instruction)
NL (1) NL7610845A (instruction)
NO (1) NO763345L (instruction)
NZ (1) NZ182165A (instruction)
SE (1) SE7510988L (instruction)
SU (2) SU638252A3 (instruction)
ZA (1) ZA765331B (instruction)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043807B1 (en) 1980-07-09 1984-05-30 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
DE69633613T2 (de) * 1995-12-28 2006-02-09 Mitsubishi Pharma Corp. 2-amino-2-(2-(4-octylphenyl)ethyl)propan-1,3-diol enthaltendes Arzneimittel zur topischen Anwendung zur Behandlung von Erkrankungen,die durch eine Störung des Immunsystems hervorgerufen werden
SI2332921T1 (sl) 2003-06-17 2016-06-30 Arena Pharmaceuticals, Inc. 8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazapin hidroklorid
EP2518053A1 (en) 2006-04-03 2012-10-31 Arena Pharmaceuticals, Inc. Process for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
ES2522587T3 (es) 2006-12-05 2014-11-17 Arena Pharmaceuticals, Inc. Procesos para preparar (R)-8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzacepina e intermedios de la misma
RU2361604C1 (ru) * 2007-10-29 2009-07-20 Федеральное агентство по высокотехнологичной медицинской помощи Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии" (ФГУ УрНИИДВиИ Росмедтехнологий) Способ лечения атопического дерматита
CN102015591B (zh) 2008-03-04 2014-01-29 艾尼纳制药公司 制备与5-ht2c激动剂(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓相关的中间体的方法
CN102648170A (zh) 2009-06-18 2012-08-22 艾尼纳制药公司 制备5-ht2c受体激动剂的方法
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
JP2013536859A (ja) 2010-09-01 2013-09-26 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−ht2cアゴニストの非吸湿性塩
MX2013002422A (es) 2010-09-01 2013-05-17 Arena Pharm Inc Sales de lorcaserina con acidos opticamente activos.
JP6272695B2 (ja) 2010-09-01 2018-01-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 体重管理のために有用な5−ht2cアゴニストの改変放出剤形
SG10201506896RA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Administration of lorcaserin to individuals with renal impairment
RU2674670C1 (ru) 2012-10-09 2018-12-12 Арена Фармасьютикалз, Инк. Способ коррекции массы тела

Also Published As

Publication number Publication date
GB1542317A (en) 1979-03-14
AU503212B2 (en) 1979-08-30
DK141622B (da) 1980-05-12
ES451979A1 (es) 1978-01-01
SU674669A3 (ru) 1979-07-15
NL7610845A (nl) 1977-04-05
JPS5242840A (en) 1977-04-04
DK439776A (instruction) 1977-04-02
CS199643B2 (en) 1980-07-31
AU1812276A (en) 1978-04-06
SE7510988L (sv) 1977-04-02
DD126278A5 (instruction) 1977-07-06
SU638252A3 (ru) 1978-12-15
NO763345L (instruction) 1977-04-04
BE846837A (fr) 1977-04-01
NZ182165A (en) 1978-07-10
LU75916A1 (instruction) 1978-05-16
AT347427B (de) 1978-12-27
FR2326183A1 (fr) 1977-04-29
DE2640972A1 (de) 1977-04-14
CS199644B2 (en) 1980-07-31
FI762660A7 (instruction) 1977-04-02
ATA682376A (de) 1978-05-15

Similar Documents

Publication Publication Date Title
JPS51131843A (en) Lipidddepleted active compound
ZA776129B (en) Pharmaceutically active compounds
ZA763652B (en) Pharmacologically active compounds
PT65590A (en) Pharmacologically active compounds
ZM14376A1 (en) Pharmacologically active compounds
PT67046B (en) Pharmacologically active compounds
PT65348B (en) Pharmacologically active compounds
JPS5228945A (en) Pharmaceutically active ooacyll 2*33diaryll33halogenn acrylaldoxim
ZA765331B (en) Novel pharmaceutically active compounds
ZA7682B (en) Pharmacologically active compounds
PT65377A (en) Pharmacologically active compounds
MW977A1 (en) Pharmacologically active compounds
ZA761324B (en) Pharmaceutically active compounds
ZM9776A1 (en) Pharmacologically active compounds
PT65839A (en) Pharmacologically active compounds
ZA762536B (en) Pharmacologically active compounds
AU2730377A (en) Pharmacologically active compounds
GB1487036A (en) Pharmaceutically useful 2-aminoacetoamido-alpha-phenylbenzylideneaminoalkanol derivatives
GB1483448A (en) Therapeutically active basic ethers
PT65759A (en) Pharmacologically active compounds
JPS5283745A (en) Pharmaceutically active compound
ZA76390B (en) Pharmacologically active compositions
ZA764183B (en) Pharmaceutically active peptides
MW2876A1 (en) Pharmacologically active compounds
MW2776A1 (en) Pharmacologically active compounds